Patents by Inventor Noemi Fusaki

Noemi Fusaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11136594
    Abstract: An objective of the present invention is to provide vectors for conveniently and efficiently producing ES-like cells in which foreign genes are not integrated into the chromosome. The present inventors discovered methods for producing ES-like cells from somatic cells using chromosomally non-integrating viral vectors. Since no foreign gene is integrated into the chromosome of the produced ES-like cells, they are advantageous in tests and research, and immunological rejection and ethical problems can be avoided in disease treatments.
    Type: Grant
    Filed: March 8, 2016
    Date of Patent: October 5, 2021
    Assignee: ID PHARMA CO., LTD.
    Inventors: Noemi Fusaki, Hiroshi Ban, Mamoru Hasegawa, Yoshikazu Yonemitsu
  • Patent number: 9695445
    Abstract: An objective of the present invention is to provide vectors for conveniently and efficiently producing ES-like cells in which foreign genes are not integrated into the chromosome. The present inventors discovered methods for producing ES-like cells from somatic cells using chromosomally non-integrating viral vectors. Since no foreign gene is integrated into the chromosome of the produced ES-like cells, they are advantageous in tests and research, and immunological rejection and ethical problems can be avoided in disease treatments.
    Type: Grant
    Filed: July 29, 2015
    Date of Patent: July 4, 2017
    Assignee: ID Pharma Co., Ltd.
    Inventors: Noemi Fusaki, Hiroshi Ban, Mamoru Hasegawa, Yoshikazu Yonemitsu
  • Publication number: 20160177337
    Abstract: An objective of the present invention is to provide vectors for conveniently and efficiently producing ES-like cells in which foreign genes are not integrated into the chromosome. The present inventors discovered methods for producing ES-like cells from somatic cells using chromosomally non-integrating viral vectors. Since no foreign gene is integrated into the chromosome of the produced ES-like cells, they are advantageous in tests and research, and immunological rejection and ethical problems can be avoided in disease treatments.
    Type: Application
    Filed: March 8, 2016
    Publication date: June 23, 2016
    Inventors: Noemi FUSAKI, Hiroshi BAN, Mamoru HASEGAWA, Yoshikazu YONEMITSU
  • Publication number: 20150337334
    Abstract: An objective of the present invention is to provide vectors for conveniently and efficiently producing ES-like cells in which foreign genes are not integrated into the chromosome. The present inventors discovered methods for producing ES-like cells from somatic cells using chromosomally non-integrating viral vectors. Since no foreign gene is integrated into the chromosome of the produced ES-like cells, they are advantageous in tests and research, and immunological rejection and ethical problems can be avoided in disease treatments.
    Type: Application
    Filed: July 29, 2015
    Publication date: November 26, 2015
    Inventors: Noemi FUSAKI, Hiroshi BAN, Mamoru HASEGAWA, Yoshikazu YONEMITSU
  • Patent number: 9127256
    Abstract: An objective of the present invention is to provide vectors for conveniently and efficiently producing ES-like cells in which foreign genes are not integrated into the chromosome. The present inventors discovered methods for producing ES-like cells from somatic cells using chromosomally non-integrating viral vectors. Since no foreign gene is integrated into the chromosome of the produced ES-like cells, they are advantageous in tests and research, and immunological rejection and ethical problems can be avoided in disease treatments.
    Type: Grant
    Filed: July 16, 2009
    Date of Patent: September 8, 2015
    Assignee: DNAVEC CORPORATION
    Inventors: Noemi Fusaki, Hiroshi Ban, Mamoru Hasegawa, Yoshikazu Yonemitsu
  • Patent number: 9090909
    Abstract: The present invention provides Sendai virus vectors in which genes that encode reprograming factors for inducing pluripotent stem cells are incorporated in a specific order, compositions comprising these vectors for gene delivery to be used in the induction of pluripotent stem cells, and uses thereof. Incorporation of the KLF gene, OCT gene, and SOX gene in a specific order into a single Sendai virus vector successfully and significantly increased the efficiency of pluripotent stem cell induction. Loading multiple reprogramming factors into a single vector can further increase the induction efficiency of pluripotent stem cells while reducing the number of necessary vectors.
    Type: Grant
    Filed: August 30, 2011
    Date of Patent: July 28, 2015
    Assignee: DNAVEC CORPORATION
    Inventors: Hiroshi Ban, Yasuji Ueda, Noemi Fusaki, Koichi Saeki, Mamoru Hasegawa
  • Publication number: 20130210150
    Abstract: The present invention provides Sendai virus vectors in which genes that encode reprograming factors for inducing pluripotent stem cells are incorporated in a specific order, compositions comprising these vectors for gene delivery to be used in the induction of pluripotent stem cells, and uses thereof. Incorporation of the KLF gene, OCT gene, and SOX gene in a specific order into a single Sendai virus vector successfully and significantly increased the efficiency of pluripotent stem cell induction. Loading multiple reprogramming factors into a single vector can further increase the induction efficiency of pluripotent stem cells while reducing the number of necessary vectors.
    Type: Application
    Filed: August 30, 2011
    Publication date: August 15, 2013
    Applicant: DNAVEC Corporation
    Inventors: Hiroshi Ban, Yasuji Ueda, Noemi Fusaki, Koichi Saeki, Mamoru Hasegawa
  • Publication number: 20110287538
    Abstract: An objective of the present invention is to provide vectors for conveniently and efficiently producing ES-like cells in which foreign genes are not integrated into the chromosome. The present inventors discovered methods for producing ES-like cells from somatic cells using chromosomally non-integrating viral vectors. Since no foreign gene is integrated into the chromosome of the produced ES-like cells, they are advantageous in tests and research, and immunological rejection and ethical problems can be avoided in disease treatments.
    Type: Application
    Filed: July 16, 2009
    Publication date: November 24, 2011
    Inventors: Noemi Fusaki, Hiroshi Ban, Mamoru Hasegawa, Yoshikazu Yonemitsu